Puma Biotechnology Q4 Loss Narrows - Quick Facts

(RTTNews) - Puma Biotechnology, Inc. (PBYI) Monday said fourth-quarter loss narrowed to $16.0 million or $0.56 per share from $21.9 million or $0.83 per share in the same period last year.

Adjusted loss for the quarter was $13.3 million or $0.46 per share. On average, five analysts polled by Thomson Reuters expected the company to report a loss of $0.49 per share for the quarter. Analysts' estimates typically exclude special items.

Operating expenses amounted to $16.0 million for the fourth quarter, compared to $22.0 million last year. Adjusted operating expenses were $13.3 million.

General and administrative expenses decreased to $3.0 million from $13.8 million last year. Research and development expenses totaled $13.0 million, up from $8.2 million last year.